| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A clinical investigation of inhibitory effect of panobinostat on CYP2D6 substrate in patients with advanced cancer
|
Feld, Ronald
|
|
2013
|
72 |
4 |
p. 747-755
|
article
|
| 2 |
A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer
|
Yeo, Chang Dong
|
|
2013
|
72 |
4 |
p. 809-814
|
article
|
| 3 |
Antitumor efficacy, toxicity and pharmacokinetics of 9-nitrocamptothecin: role of lactone ratio
|
Chen, Jun
|
|
2013
|
72 |
4 |
p. 925-929
|
article
|
| 4 |
A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumors
|
Papadopoulos, Kyriakos P.
|
|
2013
|
72 |
4 |
p. 861-868
|
article
|
| 5 |
A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma
|
Park, Inkeun
|
|
2013
|
72 |
4 |
p. 815-823
|
article
|
| 6 |
Bevacizumab confers additional advantage to the combination of trastuzumab plus pertuzumab in trastuzumab-refractory breast cancer model
|
Sun, Yuliang
|
|
2013
|
72 |
4 |
p. 733-745
|
article
|
| 7 |
Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias
|
Gojo, Ivana
|
|
2013
|
72 |
4 |
p. 897-908
|
article
|
| 8 |
Clinical evaluation of targeted arterial perfusion of verapamil and chemotherapeutic drugs in interventional therapy of advanced lung cancer
|
Huang, Jin
|
|
2013
|
72 |
4 |
p. 889-896
|
article
|
| 9 |
Disruption of ZO-1/claudin-4 interaction in relation to inflammatory responses in methotrexate-induced intestinal mucositis
|
Hamada, Kazuma
|
|
2013
|
72 |
4 |
p. 757-765
|
article
|
| 10 |
Effects of pemetrexed, gefitinib, and their combination on human colorectal cancer cells
|
Zhang, Guanzhong
|
|
2013
|
72 |
4 |
p. 767-775
|
article
|
| 11 |
Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma
|
Kim, Ki Hyang
|
|
2013
|
72 |
4 |
p. 853-860
|
article
|
| 12 |
Identification of two novel inhibitors of mTOR signaling pathway based on high content screening
|
Yan, Juming
|
|
2013
|
72 |
4 |
p. 799-808
|
article
|
| 13 |
Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins
|
Hu, Yunhui
|
|
2013
|
72 |
4 |
p. 789-798
|
article
|
| 14 |
Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma
|
Zhang, Sheng-hua
|
|
2013
|
72 |
4 |
p. 777-788
|
article
|
| 15 |
New fronts in the adjuvant treatment of GIST
|
Reichardt, Peter
|
|
2013
|
72 |
4 |
p. 715-723
|
article
|
| 16 |
Pharmacogenetically driven patient selection for a first-in-human phase I trial of batracylin in patients with advanced solid tumors and lymphomas
|
Kummar, Shivaani
|
|
2013
|
72 |
4 |
p. 917-923
|
article
|
| 17 |
Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients
|
Kim, Hye Ryun
|
|
2013
|
72 |
4 |
p. 825-835
|
article
|
| 18 |
Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib
|
Zucchetti, Massimo
|
|
2013
|
72 |
4 |
p. 879-887
|
article
|
| 19 |
Phase II study of docetaxel and vinorelbine as adjuvant chemotherapy for resected non-small cell lung cancers
|
Chaft, Jamie E.
|
|
2013
|
72 |
4 |
p. 931-934
|
article
|
| 20 |
Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
|
Song, Hunho
|
|
2013
|
72 |
4 |
p. 845-852
|
article
|
| 21 |
Receptor tyrosine kinase alterations and therapeutic opportunities in squamous cell carcinoma of the lung
|
Wang, Dong
|
|
2013
|
72 |
4 |
p. 725-731
|
article
|
| 22 |
Reversibility of regorafenib effects in hepatocellular carcinoma cells
|
D’Alessandro, Rosalba
|
|
2013
|
72 |
4 |
p. 869-877
|
article
|
| 23 |
Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC)
|
Meulenbeld, Hielke J.
|
|
|
72 |
4 |
p. 909-916
|
article
|
| 24 |
Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC)
|
Meulenbeld, Hielke J.
|
|
2013
|
72 |
4 |
p. 909-916
|
article
|
| 25 |
Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy
|
Taguchi, Takahide
|
|
2013
|
72 |
4 |
p. 837-843
|
article
|
Journal description